Originally Posted by Chris

To be fair, Moderna is only 10 years old and has never brought a vaccine to market before. HMG’s strategy seems to be to back a variety of potential vaccine approaches, most likely because different vaccination methods will show different levels of effectiveness in different sorts of patient. HMG’s chosen RNA vaccine is the one produced by Pfizer which has decades of experience and ultimately won the race to first results. It is also likely to be able to mass produce more rapidly and at greater volume.

To insinuate the EU has somehow made better choices because it happens to have some of Moderna’s product in its portfolio is absurd. That was a gamble, plain and simple. Great for them that it’s paid off, but let’s not get all moist and dewy eyed over them as if they’ve somehow done something intrinsically cleverer than anyone else.